Hemolytic Uremic Syndrome (HUS) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

aHUS Observational Long Term Follow-Up
Condition:   Atypical Hemolytic Uremic SyndromeIntervention:   Sponsor:   Alexion PharmaceuticalsEnrolling by invitation - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials

Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition:   Atypical Hemolytic-Uremic SyndromeIntervention:   Sponsor:   Alexion PharmaceuticalsRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials

aHUS Observational Long Term Follow-Up
Condition:   Atypical Hemolytic Uremic SyndromeIntervention:   Sponsor:   Alexion PharmaceuticalsEnrolling by invitation - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials

Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition:   Atypical Hemolytic-Uremic SyndromeIntervention:   Sponsor:   Alexion PharmaceuticalsRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2012 Category: Research Source Type: clinical trials

The Plasma Large-Volume Exchange RCT
Conditions:   Purpura, Thrombotic Thrombocytopenic;   Hemolytic Uremic SyndromeIntervention:   Procedure: Plasma ExchangeSponsors:   London Health Sciences Centre;   London Health Sciences CentreWithdrawn - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2011 Category: Research Source Type: clinical trials